Mira Pharmaceuticals Inc (MIRA) Stock Price, Quote & News

Company Profile

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 786 432 9792

Website: mirapharmaceuticals.com

Address:

1200 Brickell Avenue, Suite 1950 #1183, Miami, United States

TheBlueFlames Sep. 2 at 6:58 PM

Solar will be the next big thing, ELON MUSK talking about it 🚨 SUNE just got The biggest Solar Merger Agreement! 🚨 I believe they will send SUNE to the moon, make sure to position urself before this takes off.🚨 $SSM $PETZ $OLOX $MIRA :)>128

0 · Reply

Mattias7705 Sep. 2 at 3:13 PM

$MIRA its up now😁🚀

0 · Reply

Namni60 Sep. 2 at 2:40 PM

$MIRA Why would this be down today? This should be trading at 3 dollars a share!

1 · Reply

Jaespresso Sep. 2 at 1:55 PM

$MIRA

0 · Reply

xTheEi8htx Sep. 2 at 12:32 AM

Ei8ht Watchlist Premarket 7:00 AM–9:00 AM ET $GAUZ $GYGY $VSME $INBS $MIRA

0 · Reply

Skimman Sep. 1 at 10:17 PM

$MIRA its a POS...they ALL ARE

0 · Reply

switchblade0611 Sep. 1 at 10:11 PM

$MIRA afterhours running!

0 · Reply

RTPRwire Sep. 1 at 9:36 PM

Today's biggest catalyst moves on the wire (validated intraday captures through 5:15 PM ET): $BIAF ran as much as +89% — product launch $OLOX ran as much as +49% — product launch $MIRA ran as much as +39% — clinical trial results $KALA ran as much as +37% — partnership $AMBR ran as much as +31% — product launch Get real-time catalyst alerts using RTPR.

0 · Reply

topstockalerts Sep. 1 at 9:26 PM

$MIRA not chasing but definitely watching this closely

0 · Reply

Jaespresso Sep. 1 at 9:05 PM

$MIRA keep I’m mind this is a penny stock anyone trying to base movement strictly off charts is looking at this the wrong way. Especially being a biotech. This is something you hold as clinical progress in the drug portfolio continues. With the right news and clinical progress it can become insanely volatile and swing up hard. Check out VKTX in Q1 of FY24 to see what clinical progress can do to a biotech such as MIRA with no commercial drugs on the market yet.. Do your own research. Not Financial Advice!

0 · Reply